Article
MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development
13 Feb 2018
Abstract excerpt
BACKGROUND: Identification of novel MDM2 or p53 binding proteins may reveal undefined oncogenes, tumor suppressors, signaling pathways and possible treatment targets. METHODS: By means of immunoprecipitation and Mass Spectrometry analysis, we aimed to identify novel regulators of the MDM2-p53 pathway. We further clarified the impact of MYL6B on the p53 protein level and on the process of apoptosis. We also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
